STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more
Biotech startups recently closed out their best fundraising quarter in two years, signaling that the industry downturn may soon be a thing of the past.
Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of motor vehicles passing by is picking up, and the official
